English

IDM PHARMA, INC.

EDGAR

Quarterly report (10-Q) · filed 2009-05-11

59 filing records in this dataset, filed from 1996-08-12 to 2009-05-11. Explore the available filing history and original sources.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

4 thousand USD

2009-03-31 · USD

Exact inputs and evidence

Revenue: 4000 USD Source

Operating margin

-120,825%

2009-03-31 · %

Exact inputs and evidence

Operating Income: -4833000 USD Source
Revenue: 4000 USD Source

Operating cash flow

-4.72 million USD

2009-03-31 · USD

Exact inputs and evidence

Operating Cash Flow: -4718000 USD Source

Free cash flow

-4.72 million USD

2009-03-31 · USD

Exact inputs and evidence

Operating Cash Flow: -4718000 USD Source
Capital Expenditure: 3000 USD Source

Cash and cash equivalents: 7.37 million USD 2009-03-31 Source
Exact value

7371000 USD
Long-term debt including current maturities: Not available
Shares outstanding: Not available

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

746 thousand USD

2008-04-01 – 2009-03-31

Exact inputs and evidence

Revenue: 55000 USD · 2008-04-01 – 2008-06-30 Source
Revenue: 397000 USD · 2008-07-01 – 2008-09-30 Source
Revenue: 3147000 USD · 2008-01-01 – 2008-12-31 Source
Revenue: 2857000 USD · 2008-01-01 – 2008-09-30 Source
Revenue: 4000 USD · 2009-01-01 – 2009-03-31 Source

Net income

-11.6 million USD

2008-04-01 – 2009-03-31

Exact inputs and evidence

Net income: -388000 USD · 2008-04-01 – 2008-06-30 Source
Net income: -4225000 USD · 2008-07-01 – 2008-09-30 Source
Net income: -18606000 USD · 2008-01-01 – 2008-12-31 Source
Net income: -16749000 USD · 2008-01-01 – 2008-09-30 Source
Net income: -5165000 USD · 2009-01-01 – 2009-03-31 Source

Operating cash flow

-13 million USD

2008-04-01 – 2009-03-31

Exact inputs and evidence

Operating cash flow: -6062000 USD · 2008-01-01 – 2008-06-30 Source
Operating cash flow: -6856000 USD · 2008-01-01 – 2008-03-31 Source
Operating cash flow: -9440000 USD · 2008-01-01 – 2008-09-30 Source
Operating cash flow: -6062000 USD · 2008-01-01 – 2008-06-30 Source
Operating cash flow: -15153000 USD · 2008-01-01 – 2008-12-31 Source
Operating cash flow: -9440000 USD · 2008-01-01 – 2008-09-30 Source
Operating cash flow: -4718000 USD · 2009-01-01 – 2009-03-31 Source

Capital expenditure

25 thousand USD

2008-04-01 – 2009-03-31

Exact inputs and evidence

Capital expenditure: 12000 USD · 2008-01-01 – 2008-06-30 Source
Capital expenditure: 9000 USD · 2008-01-01 – 2008-03-31 Source
Capital expenditure: 29000 USD · 2008-01-01 – 2008-09-30 Source
Capital expenditure: 12000 USD · 2008-01-01 – 2008-06-30 Source
Capital expenditure: 31000 USD · 2008-01-01 – 2008-12-31 Source
Capital expenditure: 29000 USD · 2008-01-01 – 2008-09-30 Source
Capital expenditure: 3000 USD · 2009-01-01 – 2009-03-31 Source

Free cash flow

-13 million USD

2008-04-01 – 2009-03-31

Exact inputs and evidence

Operating cash flow: -6062000 USD · 2008-01-01 – 2008-06-30 Source
Operating cash flow: -6856000 USD · 2008-01-01 – 2008-03-31 Source
Operating cash flow: -9440000 USD · 2008-01-01 – 2008-09-30 Source
Operating cash flow: -6062000 USD · 2008-01-01 – 2008-06-30 Source
Operating cash flow: -15153000 USD · 2008-01-01 – 2008-12-31 Source
Operating cash flow: -9440000 USD · 2008-01-01 – 2008-09-30 Source
Operating cash flow: -4718000 USD · 2009-01-01 – 2009-03-31 Source
Capital expenditure: 12000 USD · 2008-01-01 – 2008-06-30 Source
Capital expenditure: 9000 USD · 2008-01-01 – 2008-03-31 Source
Capital expenditure: 29000 USD · 2008-01-01 – 2008-09-30 Source
Capital expenditure: 12000 USD · 2008-01-01 – 2008-06-30 Source
Capital expenditure: 31000 USD · 2008-01-01 – 2008-12-31 Source
Capital expenditure: 29000 USD · 2008-01-01 – 2008-09-30 Source
Capital expenditure: 3000 USD · 2009-01-01 – 2009-03-31 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2009-05-11.

Financial data available through: 2008-12-31.

Coverage by financial measure

Revenue: 11 of 11 periods available· newest 2008-12-31
Operating income: 11 of 11 periods available· newest 2008-12-31
Net income: 11 of 11 periods available· newest 2008-12-31
Operating cash flow: 11 of 11 periods available· newest 2008-12-31
Capital expenditure: 11 of 11 periods available· newest 2008-12-31
Total assets: 8 of 11 periods available· newest 2006-12-31
Total liabilities: 4 of 11 periods available· newest 2008-12-31
Current assets: 11 of 11 periods available· newest 2008-12-31
Current liabilities: 11 of 11 periods available· newest 2008-12-31
Cash and cash equivalents: 11 of 11 periods available· newest 2008-12-31
long term debt: No compatible figures in this window
shares outstanding: No compatible figures in this window

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
-78.5%

Prior period

USD 14.63 million

2007-01-01 – 2007-12-31
Current period

USD 3.15 million

2008-01-01 – 2008-12-31

Exact inputs and evidence

3147000 − 14630000 = -11483000 USD

14630000 USD · 2007-01-01 – 2007-12-31
Inspect prior input Prior source
3147000 USD · 2008-01-01 – 2008-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · IDM PHARMA, INC. · 2008-12-31 IDM PHARMA, INC. (edgar:822206) Year-over-year change in Revenue: -11483000 USD Concept: fundies:Revenue Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/822206?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 3147000 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/822206/0000936392-09-000146.txt#17546 Input fundies:Revenue: 14630000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/822206/0000936392-09-000146.txt#17546
The citation records this snapshot. The page link may show a newer release later.
Net income
−USD 256,000

Prior period

−USD 18.35 million

2007-01-01 – 2007-12-31
Current period

−USD 18.61 million

2008-01-01 – 2008-12-31

Exact inputs and evidence

-18606000 − -18350000 = -256000 USD

-18350000 USD · 2007-01-01 – 2007-12-31
Inspect prior input Prior source
-18606000 USD · 2008-01-01 – 2008-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · IDM PHARMA, INC. · 2008-12-31 IDM PHARMA, INC. (edgar:822206) Year-over-year change in Net income: -256000 USD Concept: fundies:NetIncome Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/822206?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -18606000 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/822206/0000936392-09-000146.txt#18969 Input fundies:NetIncome: -18350000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/822206/0000936392-09-000146.txt#18969
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+USD 2.68 million

Prior period

−USD 17.84 million

2007-01-01 – 2007-12-31
Current period

−USD 15.15 million

2008-01-01 – 2008-12-31

Exact inputs and evidence

-15153000 − -17837000 = 2684000 USD

-17837000 USD · 2007-01-01 – 2007-12-31
Inspect prior input Prior source
-15153000 USD · 2008-01-01 – 2008-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · IDM PHARMA, INC. · 2008-12-31 IDM PHARMA, INC. (edgar:822206) Year-over-year change in Operating cash flow: 2684000 USD Concept: fundies:OperatingCashFlow Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/822206?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -15153000 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/822206/0000936392-09-000146.txt#19828 Input fundies:OperatingCashFlow: -17837000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/822206/0000936392-09-000146.txt#19828
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
-87.6%

Prior period

USD 249,000

2007-01-01 – 2007-12-31
Current period

USD 31,000

2008-01-01 – 2008-12-31

Exact inputs and evidence

31000 − 249000 = -218000 USD

249000 USD · 2007-01-01 – 2007-12-31
Inspect prior input Prior source
31000 USD · 2008-01-01 – 2008-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · IDM PHARMA, INC. · 2008-12-31 IDM PHARMA, INC. (edgar:822206) Year-over-year change in Capital expenditure: -218000 USD Concept: fundies:CapitalExpenditure Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/822206?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 31000 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/822206/0000936392-09-000146.txt#19957 Input fundies:CapitalExpenditure: 249000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/822206/0000936392-09-000146.txt#19957
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2008 2008-01-01 – 2008-12-31

Revenue USD 3.15 million 100% of revenue
Operating costs Derived USD 19.07 million 606% of revenue
Operating income −USD 15.92 million −506% of revenue
Tax, interest and other Derived USD 2.69 million 85% of revenue
Net income −USD 18.61 million −591% of revenue

Cash

Operating cash flow −USD 15.15 million −482% of revenue
Capital expenditure USD 31,000 1% of revenue
Free cash flow Derived −USD 15.18 million −482% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

1999 Operating loss: operating costs were 410% of revenue.
2000 Operating loss: operating costs were 530% of revenue.
2001 Operating loss: operating costs were 138% of revenue.
2002 Operating loss: operating costs were 200% of revenue.
2003 Operating loss: operating costs were 425% of revenue.
2004 Operating loss: operating costs were 663% of revenue.
2005 Operating loss: operating costs were 569% of revenue.
2006 Operating loss: operating costs were 292% of revenue.
2007 Operating loss: operating costs were 246% of revenue.
2008 Operating loss: operating costs were 606% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
1999 1999-01-01 – 1999-12-31	4168000	17085000 Derived	-12917000	-4652000 Derived	-8265000	-9479000 Derived	Source 1999-01-01 – 1999-12-31: 4168000 USD Inspect Revenue Open source 1999-01-01 – 1999-12-31: -12917000 USD Inspect Operating Income Open source 1999-01-01 – 1999-12-31: -8265000 USD Inspect Net Income Open source 1999-01-01 – 1999-12-31: -8740000 USD Inspect Operating Cash Flow Open source 1999-01-01 – 1999-12-31: 739000 USD Inspect Capital Expenditure Open source
2000 2000-01-01 – 2000-12-31	1603000	8490000 Derived	-6887000	-2150000 Derived	-4737000	-4585000 Derived	Source 2000-01-01 – 2000-12-31: 1603000 USD Inspect Revenue Open source 2000-01-01 – 2000-12-31: -6887000 USD Inspect Operating Income Open source 2000-01-01 – 2000-12-31: -4737000 USD Inspect Net Income Open source 2000-01-01 – 2000-12-31: -4229000 USD Inspect Operating Cash Flow Open source 2000-01-01 – 2000-12-31: 356000 USD Inspect Capital Expenditure Open source
2001 2001-01-01 – 2001-12-31	8166000	11233000 Derived	-3067000	-423000 Derived	-2644000	879000 Derived	Source 2001-01-01 – 2001-12-31: 8166000 USD Inspect Revenue Open source 2001-01-01 – 2001-12-31: -3067000 USD Inspect Operating Income Open source 2001-01-01 – 2001-12-31: -2644000 USD Inspect Net Income Open source 2001-01-01 – 2001-12-31: 1172000 USD Inspect Operating Cash Flow Open source 2001-01-01 – 2001-12-31: 293000 USD Inspect Capital Expenditure Open source
2002 2002-01-01 – 2002-12-31	7070000	14144000 Derived	-7074000	-574000 Derived	-6500000	-7789000 Derived	Source 2002-01-01 – 2002-12-31: 7070000 USD Inspect Revenue Open source 2002-01-01 – 2002-12-31: -7074000 USD Inspect Operating Income Open source 2002-01-01 – 2002-12-31: -6500000 USD Inspect Net Income Open source 2002-01-01 – 2002-12-31: -7054000 USD Inspect Operating Cash Flow Open source 2002-01-01 – 2002-12-31: 735000 USD Inspect Capital Expenditure Open source
2003 2003-01-01 – 2003-12-31	6088000	25845000 Derived	-19757000	-1325000 Derived	-18432000	-16306000 Derived	Source 2003-01-01 – 2003-12-31: 6088000 USD Inspect Revenue Open source 2003-01-01 – 2003-12-31: -19757000 USD Inspect Operating Income Open source 2003-01-01 – 2003-12-31: -18432000 USD Inspect Net Income Open source 2003-01-01 – 2003-12-31: -15912000 USD Inspect Operating Cash Flow Open source 2003-01-01 – 2003-12-31: 394000 USD Inspect Capital Expenditure Open source
2004 2004-01-01 – 2004-12-31	5805000	38496000 Derived	-32691000	-1034000 Derived	-31657000	-18052000 Derived	Source 2004-01-01 – 2004-12-31: 5805000 USD Inspect Revenue Open source 2004-01-01 – 2004-12-31: -32691000 USD Inspect Operating Income Open source 2004-01-01 – 2004-12-31: -31657000 USD Inspect Net Income Open source 2004-01-01 – 2004-12-31: -17547000 USD Inspect Operating Cash Flow Open source 2004-01-01 – 2004-12-31: 505000 USD Inspect Capital Expenditure Open source
2005 2005-01-01 – 2005-12-31	8539000	48583000 Derived	-40044000	-835000 Derived	-39209000	-22147000 Derived	Source 2005-01-01 – 2005-12-31: 8539000 USD Inspect Revenue Open source 2005-01-01 – 2005-12-31: -40044000 USD Inspect Operating Income Open source 2005-01-01 – 2005-12-31: -39209000 USD Inspect Net Income Open source 2005-01-01 – 2005-12-31: -21633000 USD Inspect Operating Cash Flow Open source 2005-01-01 – 2005-12-31: 514000 USD Inspect Capital Expenditure Open source
2006 2006-01-01 – 2006-12-31	11286000	32928000 Derived	-21642000	1813000 Derived	-23455000	-17707000 Derived	Source 2006-01-01 – 2006-12-31: 11286000 USD Inspect Revenue Open source 2006-01-01 – 2006-12-31: -21642000 USD Inspect Operating Income Open source 2006-01-01 – 2006-12-31: -23455000 USD Inspect Net Income Open source 2006-01-01 – 2006-12-31: -17491000 USD Inspect Operating Cash Flow Open source 2006-01-01 – 2006-12-31: 216000 USD Inspect Capital Expenditure Open source
2007 2007-01-01 – 2007-12-31	14630000	35990000 Derived	-21360000	-3010000 Derived	-18350000	-18086000 Derived	Source 2007-01-01 – 2007-12-31: 14630000 USD Inspect Revenue Open source 2007-01-01 – 2007-12-31: -21360000 USD Inspect Operating Income Open source 2007-01-01 – 2007-12-31: -18350000 USD Inspect Net Income Open source 2007-01-01 – 2007-12-31: -17837000 USD Inspect Operating Cash Flow Open source 2007-01-01 – 2007-12-31: 249000 USD Inspect Capital Expenditure Open source
2008 2008-01-01 – 2008-12-31	3147000	19067000 Derived	-15920000	2686000 Derived	-18606000	-15184000 Derived	Source 2008-01-01 – 2008-12-31: 3147000 USD Inspect Revenue Open source 2008-01-01 – 2008-12-31: -15920000 USD Inspect Operating Income Open source 2008-01-01 – 2008-12-31: -18606000 USD Inspect Net Income Open source 2008-01-01 – 2008-12-31: -15153000 USD Inspect Operating Cash Flow Open source 2008-01-01 – 2008-12-31: 31000 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 3.1M 2008

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
19991999-12-31	Revenue	4168000	Revenue: 4168000 Open source
20002000-12-31	Revenue	1603000	Revenue: 1603000 Open source
20012001-12-31	Revenue	8166000	Revenue: 8166000 Open source
20022002-12-31	Revenue	7070000	Revenue: 7070000 Open source
20032003-12-31	Revenue	6088000	Revenue: 6088000 Open source
20042004-12-31	Revenue	5805000	Revenue: 5805000 Open source
20052005-12-31	Revenue	8539000	Revenue: 8539000 Open source
20062006-12-31	Revenue	11286000	Revenue: 11286000 Open source
20072007-12-31	Revenue	14630000	Revenue: 14630000 Open source
20082008-12-31	Revenue	3147000	Revenue: 3147000 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

-78.5% 2008

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
19991999-12-31	Year over year	12.7%	Revenue: 4168000 Open source Revenue: 3697000 Open source
20002000-12-31	Year over year	-61.5%	Revenue: 1603000 Open source Revenue: 4168000 Open source
20012001-12-31	Year over year	409.4%	Revenue: 8166000 Open source Revenue: 1603000 Open source
20022002-12-31	Year over year	-13.4%	Revenue: 7070000 Open source Revenue: 8166000 Open source
20032003-12-31	Year over year	-13.9%	Revenue: 6088000 Open source Revenue: 7070000 Open source
20042004-12-31	Year over year	-4.6%	Revenue: 5805000 Open source Revenue: 6088000 Open source
20052005-12-31	Year over year	47.1%	Revenue: 8539000 Open source Revenue: 5805000 Open source
20062006-12-31	Year over year	32.2%	Revenue: 11286000 Open source Revenue: 8539000 Open source
20072007-12-31	Year over year	29.6%	Revenue: 14630000 Open source Revenue: 11286000 Open source
20082008-12-31	Year over year	-78.5%	Revenue: 3147000 Open source Revenue: 14630000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -505.9% 2008

Net margin -591.2% 2008

Free cash flow margin -482.5% 2008

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
19991999-12-31	Operating margin	-309.9%	Operating Income: -12917000 Open source Revenue: 4168000 Open source
20002000-12-31	Operating margin	-429.6%	Operating Income: -6887000 Open source Revenue: 1603000 Open source
20012001-12-31	Operating margin	-37.6%	Operating Income: -3067000 Open source Revenue: 8166000 Open source
20022002-12-31	Operating margin	-100.1%	Operating Income: -7074000 Open source Revenue: 7070000 Open source
20032003-12-31	Operating margin	-324.5%	Operating Income: -19757000 Open source Revenue: 6088000 Open source
20042004-12-31	Operating margin	-563.2%	Operating Income: -32691000 Open source Revenue: 5805000 Open source
20052005-12-31	Operating margin	-469%	Operating Income: -40044000 Open source Revenue: 8539000 Open source
20062006-12-31	Operating margin	-191.8%	Operating Income: -21642000 Open source Revenue: 11286000 Open source
20072007-12-31	Operating margin	-146%	Operating Income: -21360000 Open source Revenue: 14630000 Open source
20082008-12-31	Operating margin	-505.9%	Operating Income: -15920000 Open source Revenue: 3147000 Open source
19991999-12-31	Net margin	-198.3%	Net Income: -8265000 Open source Revenue: 4168000 Open source
20002000-12-31	Net margin	-295.5%	Net Income: -4737000 Open source Revenue: 1603000 Open source
20012001-12-31	Net margin	-32.4%	Net Income: -2644000 Open source Revenue: 8166000 Open source
20022002-12-31	Net margin	-91.9%	Net Income: -6500000 Open source Revenue: 7070000 Open source
20032003-12-31	Net margin	-302.8%	Net Income: -18432000 Open source Revenue: 6088000 Open source
20042004-12-31	Net margin	-545.3%	Net Income: -31657000 Open source Revenue: 5805000 Open source
20052005-12-31	Net margin	-459.2%	Net Income: -39209000 Open source Revenue: 8539000 Open source
20062006-12-31	Net margin	-207.8%	Net Income: -23455000 Open source Revenue: 11286000 Open source
20072007-12-31	Net margin	-125.4%	Net Income: -18350000 Open source Revenue: 14630000 Open source
20082008-12-31	Net margin	-591.2%	Net Income: -18606000 Open source Revenue: 3147000 Open source
19991999-12-31	Free cash flow margin	-227.4%	Revenue: 4168000 Open source Operating Cash Flow: -8740000 Open source Capital Expenditure: 739000 Open source
20002000-12-31	Free cash flow margin	-286%	Revenue: 1603000 Open source Operating Cash Flow: -4229000 Open source Capital Expenditure: 356000 Open source
20012001-12-31	Free cash flow margin	10.8%	Revenue: 8166000 Open source Operating Cash Flow: 1172000 Open source Capital Expenditure: 293000 Open source
20022002-12-31	Free cash flow margin	-110.2%	Revenue: 7070000 Open source Operating Cash Flow: -7054000 Open source Capital Expenditure: 735000 Open source
20032003-12-31	Free cash flow margin	-267.8%	Revenue: 6088000 Open source Operating Cash Flow: -15912000 Open source Capital Expenditure: 394000 Open source
20042004-12-31	Free cash flow margin	-311%	Revenue: 5805000 Open source Operating Cash Flow: -17547000 Open source Capital Expenditure: 505000 Open source
20052005-12-31	Free cash flow margin	-259.4%	Revenue: 8539000 Open source Operating Cash Flow: -21633000 Open source Capital Expenditure: 514000 Open source
20062006-12-31	Free cash flow margin	-156.9%	Revenue: 11286000 Open source Operating Cash Flow: -17491000 Open source Capital Expenditure: 216000 Open source
20072007-12-31	Free cash flow margin	-123.6%	Revenue: 14630000 Open source Operating Cash Flow: -17837000 Open source Capital Expenditure: 249000 Open source
20082008-12-31	Free cash flow margin	-482.5%	Revenue: 3147000 Open source Operating Cash Flow: -15153000 Open source Capital Expenditure: 31000 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -15.2M 2008

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
19991999-12-31	Operating cash flow	-8740000	Operating Cash Flow: -8740000 Open source
20002000-12-31	Operating cash flow	-4229000	Operating Cash Flow: -4229000 Open source
20012001-12-31	Operating cash flow	1172000	Operating Cash Flow: 1172000 Open source
20022002-12-31	Operating cash flow	-7054000	Operating Cash Flow: -7054000 Open source
20032003-12-31	Operating cash flow	-15912000	Operating Cash Flow: -15912000 Open source
20042004-12-31	Operating cash flow	-17547000	Operating Cash Flow: -17547000 Open source
20052005-12-31	Operating cash flow	-21633000	Operating Cash Flow: -21633000 Open source
20062006-12-31	Operating cash flow	-17491000	Operating Cash Flow: -17491000 Open source
20072007-12-31	Operating cash flow	-17837000	Operating Cash Flow: -17837000 Open source
20082008-12-31	Operating cash flow	-15153000	Operating Cash Flow: -15153000 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -15.2M 2008

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
19991999-12-31	Free cash flow	-9479000	Operating Cash Flow: -8740000 Open source Capital Expenditure: 739000 Open source
20002000-12-31	Free cash flow	-4585000	Operating Cash Flow: -4229000 Open source Capital Expenditure: 356000 Open source
20012001-12-31	Free cash flow	879000	Operating Cash Flow: 1172000 Open source Capital Expenditure: 293000 Open source
20022002-12-31	Free cash flow	-7789000	Operating Cash Flow: -7054000 Open source Capital Expenditure: 735000 Open source
20032003-12-31	Free cash flow	-16306000	Operating Cash Flow: -15912000 Open source Capital Expenditure: 394000 Open source
20042004-12-31	Free cash flow	-18052000	Operating Cash Flow: -17547000 Open source Capital Expenditure: 505000 Open source
20052005-12-31	Free cash flow	-22147000	Operating Cash Flow: -21633000 Open source Capital Expenditure: 514000 Open source
20062006-12-31	Free cash flow	-17707000	Operating Cash Flow: -17491000 Open source Capital Expenditure: 216000 Open source
20072007-12-31	Free cash flow	-18086000	Operating Cash Flow: -17837000 Open source Capital Expenditure: 249000 Open source
20082008-12-31	Free cash flow	-15184000	Operating Cash Flow: -15153000 Open source Capital Expenditure: 31000 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

58.2% 2006

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
1999-12-31	Liabilities / assets	Not reported	Total Assets: 12705000 Open source
2000-12-31	Liabilities / assets	Not reported	Total Assets: 14486000 Open source
2001-12-31	Liabilities / assets	Not reported	Total Assets: 23910000 Open source
2002-12-31	Liabilities / assets	Not reported	Total Assets: 15528000 Open source
2003-12-31	Liabilities / assets	Not reported	Total Assets: 12693000 Open source
2004-12-31	Liabilities / assets	Not reported	Total Assets: 55289000 Open source
20052005-12-31	Liabilities / assets	Not reported	Total Liabilities: 14143000 Open source
20062006-12-31	Liabilities / assets	58.2%	Total Liabilities: 14186000 Open source Total Assets: 24382000 Open source
20072007-12-31	Liabilities / assets	Not reported	Total Liabilities: 14036000 Open source
20082008-12-31	Liabilities / assets	Not reported	Total Liabilities: 10527000 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

1.45× 2008

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
19991999-12-31	Current assets / current liabilities	4.86×	Current Assets: 8715000 Open source Current Liabilities: 1792000 Open source
20002000-12-31	Current assets / current liabilities	5.35×	Current Assets: 10100000 Open source Current Liabilities: 1887000 Open source
20012001-12-31	Current assets / current liabilities	4.54×	Current Assets: 19743000 Open source Current Liabilities: 4350000 Open source
20022002-12-31	Current assets / current liabilities	3.81×	Current Assets: 10453000 Open source Current Liabilities: 2745000 Open source
20032003-12-31	Current assets / current liabilities	2.75×	Current Assets: 7614000 Open source Current Liabilities: 2770000 Open source
20042004-12-31	Current assets / current liabilities	5.32×	Current Assets: 45772000 Open source Current Liabilities: 8603000 Open source
20052005-12-31	Current assets / current liabilities	3.13×	Current Assets: 32895000 Open source Current Liabilities: 10514000 Open source
20062006-12-31	Current assets / current liabilities	1.42×	Current Assets: 15154000 Open source Current Liabilities: 10636000 Open source
20072007-12-31	Current assets / current liabilities	2.73×	Current Assets: 33168000 Open source Current Liabilities: 12162000 Open source
20082008-12-31	Current assets / current liabilities	1.45×	Current Assets: 13507000 Open source Current Liabilities: 9316000 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
1999 1999-01-01 – 1999-12-31	−USD 8.27 million Exact value Exact value: -8265000 USD 1999-01-01 – 1999-12-31: -8265000 USD Inspect Net Income Open source Share or cite Citation for Net Income · IDM PHARMA, INC. · 1999-12-31 IDM PHARMA, INC. (edgar:822206) Net Income: -8265000 USD Concept: fundies:NetIncome Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/822206/explain?concept=fundies%3ANetIncome&period=1999-12-31&surface=latest&period_type=duration&start=1999-01-01&unit=USD&dimensions= Input fundies:NetIncome: -8265000 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/822206/0000936392-02-000403.txt#10860 The citation records this snapshot. The page link may show a newer release later.	−USD 8.74 million Exact value Exact value: -8740000 USD 1999-01-01 – 1999-12-31: -8740000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · IDM PHARMA, INC. · 1999-12-31 IDM PHARMA, INC. (edgar:822206) Operating Cash Flow: -8740000 USD Concept: fundies:OperatingCashFlow Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/822206/explain?concept=fundies%3AOperatingCashFlow&period=1999-12-31&surface=latest&period_type=duration&start=1999-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -8740000 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/822206/0000936392-02-000403.txt#11217 The citation records this snapshot. The page link may show a newer release later.	USD 739,000 Exact value Exact value: 739000 USD 1999-01-01 – 1999-12-31: 739000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · IDM PHARMA, INC. · 1999-12-31 IDM PHARMA, INC. (edgar:822206) Capital Expenditure: 739000 USD Concept: fundies:CapitalExpenditure Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/822206/explain?concept=fundies%3ACapitalExpenditure&period=1999-12-31&surface=latest&period_type=duration&start=1999-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 739000 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/822206/0000936392-02-000403.txt#11357 The citation records this snapshot. The page link may show a newer release later.	−USD 9.48 million Calculation and evidence -8740000 − 739000 USD Exact free cash flow: -9479000 USD 1999-01-01 – 1999-12-31: -8740000 USD · Inspect Operating Cash Flow · Source 1999-01-01 – 1999-12-31: 739000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · IDM PHARMA, INC. · 1999-12-31 IDM PHARMA, INC. (edgar:822206) Free cash flow: -9479000 USD Concept: free-cash-flow Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/822206?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -8740000 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/822206/0000936392-02-000403.txt#11217 Input fundies:CapitalExpenditure: 739000 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/822206/0000936392-02-000403.txt#11357 The citation records this snapshot. The page link may show a newer release later.
2000 2000-01-01 – 2000-12-31	−USD 4.74 million Exact value Exact value: -4737000 USD 2000-01-01 – 2000-12-31: -4737000 USD Inspect Net Income Open source Share or cite Citation for Net Income · IDM PHARMA, INC. · 2000-12-31 IDM PHARMA, INC. (edgar:822206) Net Income: -4737000 USD Concept: fundies:NetIncome Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/822206/explain?concept=fundies%3ANetIncome&period=2000-12-31&surface=latest&period_type=duration&start=2000-01-01&unit=USD&dimensions= Input fundies:NetIncome: -4737000 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/822206/0000936392-03-000380.txt#15358 The citation records this snapshot. The page link may show a newer release later.	−USD 4.23 million Exact value Exact value: -4229000 USD 2000-01-01 – 2000-12-31: -4229000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · IDM PHARMA, INC. · 2000-12-31 IDM PHARMA, INC. (edgar:822206) Operating Cash Flow: -4229000 USD Concept: fundies:OperatingCashFlow Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/822206/explain?concept=fundies%3AOperatingCashFlow&period=2000-12-31&surface=latest&period_type=duration&start=2000-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -4229000 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/822206/0000936392-03-000380.txt#15694 The citation records this snapshot. The page link may show a newer release later.	USD 356,000 Exact value Exact value: 356000 USD 2000-01-01 – 2000-12-31: 356000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · IDM PHARMA, INC. · 2000-12-31 IDM PHARMA, INC. (edgar:822206) Capital Expenditure: 356000 USD Concept: fundies:CapitalExpenditure Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/822206/explain?concept=fundies%3ACapitalExpenditure&period=2000-12-31&surface=latest&period_type=duration&start=2000-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 356000 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/822206/0000936392-03-000380.txt#15794 The citation records this snapshot. The page link may show a newer release later.	−USD 4.59 million Calculation and evidence -4229000 − 356000 USD Exact free cash flow: -4585000 USD 2000-01-01 – 2000-12-31: -4229000 USD · Inspect Operating Cash Flow · Source 2000-01-01 – 2000-12-31: 356000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · IDM PHARMA, INC. · 2000-12-31 IDM PHARMA, INC. (edgar:822206) Free cash flow: -4585000 USD Concept: free-cash-flow Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/822206?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -4229000 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/822206/0000936392-03-000380.txt#15694 Input fundies:CapitalExpenditure: 356000 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/822206/0000936392-03-000380.txt#15794 The citation records this snapshot. The page link may show a newer release later.
2001 2001-01-01 – 2001-12-31	−USD 2.64 million Exact value Exact value: -2644000 USD 2001-01-01 – 2001-12-31: -2644000 USD Inspect Net Income Open source Share or cite Citation for Net Income · IDM PHARMA, INC. · 2001-12-31 IDM PHARMA, INC. (edgar:822206) Net Income: -2644000 USD Concept: fundies:NetIncome Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/822206/explain?concept=fundies%3ANetIncome&period=2001-12-31&surface=latest&period_type=duration&start=2001-01-01&unit=USD&dimensions= Input fundies:NetIncome: -2644000 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/822206/0000936392-04-000408.txt#17095 The citation records this snapshot. The page link may show a newer release later.	USD 1.17 million Exact value Exact value: 1172000 USD 2001-01-01 – 2001-12-31: 1172000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · IDM PHARMA, INC. · 2001-12-31 IDM PHARMA, INC. (edgar:822206) Operating Cash Flow: 1172000 USD Concept: fundies:OperatingCashFlow Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/822206/explain?concept=fundies%3AOperatingCashFlow&period=2001-12-31&surface=latest&period_type=duration&start=2001-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 1172000 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/822206/0000936392-04-000408.txt#17388 The citation records this snapshot. The page link may show a newer release later.	USD 293,000 Exact value Exact value: 293000 USD 2001-01-01 – 2001-12-31: 293000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · IDM PHARMA, INC. · 2001-12-31 IDM PHARMA, INC. (edgar:822206) Capital Expenditure: 293000 USD Concept: fundies:CapitalExpenditure Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/822206/explain?concept=fundies%3ACapitalExpenditure&period=2001-12-31&surface=latest&period_type=duration&start=2001-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 293000 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/822206/0000936392-04-000408.txt#17428 The citation records this snapshot. The page link may show a newer release later.	USD 879,000 Calculation and evidence 1172000 − 293000 USD Exact free cash flow: 879000 USD 2001-01-01 – 2001-12-31: 1172000 USD · Inspect Operating Cash Flow · Source 2001-01-01 – 2001-12-31: 293000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · IDM PHARMA, INC. · 2001-12-31 IDM PHARMA, INC. (edgar:822206) Free cash flow: 879000 USD Concept: free-cash-flow Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/822206?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 1172000 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/822206/0000936392-04-000408.txt#17388 Input fundies:CapitalExpenditure: 293000 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/822206/0000936392-04-000408.txt#17428 The citation records this snapshot. The page link may show a newer release later.
2002 2002-01-01 – 2002-12-31	−USD 6.5 million Exact value Exact value: -6500000 USD 2002-01-01 – 2002-12-31: -6500000 USD Inspect Net Income Open source Share or cite Citation for Net Income · IDM PHARMA, INC. · 2002-12-31 IDM PHARMA, INC. (edgar:822206) Net Income: -6500000 USD Concept: fundies:NetIncome Period: 2002-01-01 to 2002-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/822206/explain?concept=fundies%3ANetIncome&period=2002-12-31&surface=latest&period_type=duration&start=2002-01-01&unit=USD&dimensions= Input fundies:NetIncome: -6500000 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/822206/0000950134-05-012367.txt#17182 The citation records this snapshot. The page link may show a newer release later.	−USD 7.05 million Exact value Exact value: -7054000 USD 2002-01-01 – 2002-12-31: -7054000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · IDM PHARMA, INC. · 2002-12-31 IDM PHARMA, INC. (edgar:822206) Operating Cash Flow: -7054000 USD Concept: fundies:OperatingCashFlow Period: 2002-01-01 to 2002-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/822206/explain?concept=fundies%3AOperatingCashFlow&period=2002-12-31&surface=latest&period_type=duration&start=2002-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -7054000 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/822206/0000950134-05-012367.txt#17522 The citation records this snapshot. The page link may show a newer release later.	USD 735,000 Exact value Exact value: 735000 USD 2002-01-01 – 2002-12-31: 735000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · IDM PHARMA, INC. · 2002-12-31 IDM PHARMA, INC. (edgar:822206) Capital Expenditure: 735000 USD Concept: fundies:CapitalExpenditure Period: 2002-01-01 to 2002-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/822206/explain?concept=fundies%3ACapitalExpenditure&period=2002-12-31&surface=latest&period_type=duration&start=2002-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 735000 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/822206/0000950134-05-012367.txt#17560 The citation records this snapshot. The page link may show a newer release later.	−USD 7.79 million Calculation and evidence -7054000 − 735000 USD Exact free cash flow: -7789000 USD 2002-01-01 – 2002-12-31: -7054000 USD · Inspect Operating Cash Flow · Source 2002-01-01 – 2002-12-31: 735000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · IDM PHARMA, INC. · 2002-12-31 IDM PHARMA, INC. (edgar:822206) Free cash flow: -7789000 USD Concept: free-cash-flow Period: 2002-01-01 to 2002-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/822206?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -7054000 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/822206/0000950134-05-012367.txt#17522 Input fundies:CapitalExpenditure: 735000 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/822206/0000950134-05-012367.txt#17560 The citation records this snapshot. The page link may show a newer release later.
2003 2003-01-01 – 2003-12-31	−USD 18.43 million Exact value Exact value: -18432000 USD 2003-01-01 – 2003-12-31: -18432000 USD Inspect Net Income Open source Share or cite Citation for Net Income · IDM PHARMA, INC. · 2003-12-31 IDM PHARMA, INC. (edgar:822206) Net Income: -18432000 USD Concept: fundies:NetIncome Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/822206/explain?concept=fundies%3ANetIncome&period=2003-12-31&surface=latest&period_type=duration&start=2003-01-01&unit=USD&dimensions= Input fundies:NetIncome: -18432000 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/822206/0000936392-06-000301.txt#19302 The citation records this snapshot. The page link may show a newer release later.	−USD 15.91 million Exact value Exact value: -15912000 USD 2003-01-01 – 2003-12-31: -15912000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · IDM PHARMA, INC. · 2003-12-31 IDM PHARMA, INC. (edgar:822206) Operating Cash Flow: -15912000 USD Concept: fundies:OperatingCashFlow Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/822206/explain?concept=fundies%3AOperatingCashFlow&period=2003-12-31&surface=latest&period_type=duration&start=2003-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -15912000 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/822206/0000936392-06-000301.txt#19663 The citation records this snapshot. The page link may show a newer release later.	USD 394,000 Exact value Exact value: 394000 USD 2003-01-01 – 2003-12-31: 394000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · IDM PHARMA, INC. · 2003-12-31 IDM PHARMA, INC. (edgar:822206) Capital Expenditure: 394000 USD Concept: fundies:CapitalExpenditure Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/822206/explain?concept=fundies%3ACapitalExpenditure&period=2003-12-31&surface=latest&period_type=duration&start=2003-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 394000 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/822206/0000936392-06-000301.txt#19720 The citation records this snapshot. The page link may show a newer release later.	−USD 16.31 million Calculation and evidence -15912000 − 394000 USD Exact free cash flow: -16306000 USD 2003-01-01 – 2003-12-31: -15912000 USD · Inspect Operating Cash Flow · Source 2003-01-01 – 2003-12-31: 394000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · IDM PHARMA, INC. · 2003-12-31 IDM PHARMA, INC. (edgar:822206) Free cash flow: -16306000 USD Concept: free-cash-flow Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/822206?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -15912000 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/822206/0000936392-06-000301.txt#19663 Input fundies:CapitalExpenditure: 394000 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/822206/0000936392-06-000301.txt#19720 The citation records this snapshot. The page link may show a newer release later.
2004 2004-01-01 – 2004-12-31	−USD 31.66 million Exact value Exact value: -31657000 USD 2004-01-01 – 2004-12-31: -31657000 USD Inspect Net Income Open source Share or cite Citation for Net Income · IDM PHARMA, INC. · 2004-12-31 IDM PHARMA, INC. (edgar:822206) Net Income: -31657000 USD Concept: fundies:NetIncome Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/822206/explain?concept=fundies%3ANetIncome&period=2004-12-31&surface=latest&period_type=duration&start=2004-01-01&unit=USD&dimensions= Input fundies:NetIncome: -31657000 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/822206/0000936392-07-000254.txt#18878 The citation records this snapshot. The page link may show a newer release later.	−USD 17.55 million Exact value Exact value: -17547000 USD 2004-01-01 – 2004-12-31: -17547000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · IDM PHARMA, INC. · 2004-12-31 IDM PHARMA, INC. (edgar:822206) Operating Cash Flow: -17547000 USD Concept: fundies:OperatingCashFlow Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/822206/explain?concept=fundies%3AOperatingCashFlow&period=2004-12-31&surface=latest&period_type=duration&start=2004-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -17547000 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/822206/0000936392-07-000254.txt#19675 The citation records this snapshot. The page link may show a newer release later.	USD 505,000 Exact value Exact value: 505000 USD 2004-01-01 – 2004-12-31: 505000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · IDM PHARMA, INC. · 2004-12-31 IDM PHARMA, INC. (edgar:822206) Capital Expenditure: 505000 USD Concept: fundies:CapitalExpenditure Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/822206/explain?concept=fundies%3ACapitalExpenditure&period=2004-12-31&surface=latest&period_type=duration&start=2004-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 505000 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/822206/0000936392-07-000254.txt#19807 The citation records this snapshot. The page link may show a newer release later.	−USD 18.05 million Calculation and evidence -17547000 − 505000 USD Exact free cash flow: -18052000 USD 2004-01-01 – 2004-12-31: -17547000 USD · Inspect Operating Cash Flow · Source 2004-01-01 – 2004-12-31: 505000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · IDM PHARMA, INC. · 2004-12-31 IDM PHARMA, INC. (edgar:822206) Free cash flow: -18052000 USD Concept: free-cash-flow Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/822206?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -17547000 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/822206/0000936392-07-000254.txt#19675 Input fundies:CapitalExpenditure: 505000 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/822206/0000936392-07-000254.txt#19807 The citation records this snapshot. The page link may show a newer release later.
2005 2005-01-01 – 2005-12-31	−USD 39.21 million Exact value Exact value: -39209000 USD 2005-01-01 – 2005-12-31: -39209000 USD Inspect Net Income Open source Share or cite Citation for Net Income · IDM PHARMA, INC. · 2005-12-31 IDM PHARMA, INC. (edgar:822206) Net Income: -39209000 USD Concept: fundies:NetIncome Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/822206/explain?concept=fundies%3ANetIncome&period=2005-12-31&surface=latest&period_type=duration&start=2005-01-01&unit=USD&dimensions= Input fundies:NetIncome: -39209000 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/822206/0000936392-08-000226.txt#18576 The citation records this snapshot. The page link may show a newer release later.	−USD 21.63 million Exact value Exact value: -21633000 USD 2005-01-01 – 2005-12-31: -21633000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · IDM PHARMA, INC. · 2005-12-31 IDM PHARMA, INC. (edgar:822206) Operating Cash Flow: -21633000 USD Concept: fundies:OperatingCashFlow Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/822206/explain?concept=fundies%3AOperatingCashFlow&period=2005-12-31&surface=latest&period_type=duration&start=2005-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -21633000 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/822206/0000936392-07-000254.txt#19675 The citation records this snapshot. The page link may show a newer release later.	USD 514,000 Exact value Exact value: 514000 USD 2005-01-01 – 2005-12-31: 514000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · IDM PHARMA, INC. · 2005-12-31 IDM PHARMA, INC. (edgar:822206) Capital Expenditure: 514000 USD Concept: fundies:CapitalExpenditure Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/822206/explain?concept=fundies%3ACapitalExpenditure&period=2005-12-31&surface=latest&period_type=duration&start=2005-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 514000 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/822206/0000936392-07-000254.txt#19807 The citation records this snapshot. The page link may show a newer release later.	−USD 22.15 million Calculation and evidence -21633000 − 514000 USD Exact free cash flow: -22147000 USD 2005-01-01 – 2005-12-31: -21633000 USD · Inspect Operating Cash Flow · Source 2005-01-01 – 2005-12-31: 514000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · IDM PHARMA, INC. · 2005-12-31 IDM PHARMA, INC. (edgar:822206) Free cash flow: -22147000 USD Concept: free-cash-flow Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/822206?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -21633000 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/822206/0000936392-07-000254.txt#19675 Input fundies:CapitalExpenditure: 514000 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/822206/0000936392-07-000254.txt#19807 The citation records this snapshot. The page link may show a newer release later.
2006 2006-01-01 – 2006-12-31	−USD 23.46 million Exact value Exact value: -23455000 USD 2006-01-01 – 2006-12-31: -23455000 USD Inspect Net Income Open source Share or cite Citation for Net Income · IDM PHARMA, INC. · 2006-12-31 IDM PHARMA, INC. (edgar:822206) Net Income: -23455000 USD Concept: fundies:NetIncome Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/822206/explain?concept=fundies%3ANetIncome&period=2006-12-31&surface=latest&period_type=duration&start=2006-01-01&unit=USD&dimensions= Input fundies:NetIncome: -23455000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/822206/0000936392-09-000146.txt#18969 The citation records this snapshot. The page link may show a newer release later.	−USD 17.49 million Exact value Exact value: -17491000 USD 2006-01-01 – 2006-12-31: -17491000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · IDM PHARMA, INC. · 2006-12-31 IDM PHARMA, INC. (edgar:822206) Operating Cash Flow: -17491000 USD Concept: fundies:OperatingCashFlow Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/822206/explain?concept=fundies%3AOperatingCashFlow&period=2006-12-31&surface=latest&period_type=duration&start=2006-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -17491000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/822206/0000936392-09-000146.txt#19828 The citation records this snapshot. The page link may show a newer release later.	USD 216,000 Exact value Exact value: 216000 USD 2006-01-01 – 2006-12-31: 216000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · IDM PHARMA, INC. · 2006-12-31 IDM PHARMA, INC. (edgar:822206) Capital Expenditure: 216000 USD Concept: fundies:CapitalExpenditure Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/822206/explain?concept=fundies%3ACapitalExpenditure&period=2006-12-31&surface=latest&period_type=duration&start=2006-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 216000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/822206/0000936392-09-000146.txt#19957 The citation records this snapshot. The page link may show a newer release later.	−USD 17.71 million Calculation and evidence -17491000 − 216000 USD Exact free cash flow: -17707000 USD 2006-01-01 – 2006-12-31: -17491000 USD · Inspect Operating Cash Flow · Source 2006-01-01 – 2006-12-31: 216000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · IDM PHARMA, INC. · 2006-12-31 IDM PHARMA, INC. (edgar:822206) Free cash flow: -17707000 USD Concept: free-cash-flow Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/822206?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -17491000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/822206/0000936392-09-000146.txt#19828 Input fundies:CapitalExpenditure: 216000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/822206/0000936392-09-000146.txt#19957 The citation records this snapshot. The page link may show a newer release later.
2007 2007-01-01 – 2007-12-31	−USD 18.35 million Exact value Exact value: -18350000 USD 2007-01-01 – 2007-12-31: -18350000 USD Inspect Net Income Open source Share or cite Citation for Net Income · IDM PHARMA, INC. · 2007-12-31 IDM PHARMA, INC. (edgar:822206) Net Income: -18350000 USD Concept: fundies:NetIncome Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/822206/explain?concept=fundies%3ANetIncome&period=2007-12-31&surface=latest&period_type=duration&start=2007-01-01&unit=USD&dimensions= Input fundies:NetIncome: -18350000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/822206/0000936392-09-000146.txt#18969 The citation records this snapshot. The page link may show a newer release later.	−USD 17.84 million Exact value Exact value: -17837000 USD 2007-01-01 – 2007-12-31: -17837000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · IDM PHARMA, INC. · 2007-12-31 IDM PHARMA, INC. (edgar:822206) Operating Cash Flow: -17837000 USD Concept: fundies:OperatingCashFlow Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/822206/explain?concept=fundies%3AOperatingCashFlow&period=2007-12-31&surface=latest&period_type=duration&start=2007-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -17837000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/822206/0000936392-09-000146.txt#19828 The citation records this snapshot. The page link may show a newer release later.	USD 249,000 Exact value Exact value: 249000 USD 2007-01-01 – 2007-12-31: 249000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · IDM PHARMA, INC. · 2007-12-31 IDM PHARMA, INC. (edgar:822206) Capital Expenditure: 249000 USD Concept: fundies:CapitalExpenditure Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/822206/explain?concept=fundies%3ACapitalExpenditure&period=2007-12-31&surface=latest&period_type=duration&start=2007-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 249000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/822206/0000936392-09-000146.txt#19957 The citation records this snapshot. The page link may show a newer release later.	−USD 18.09 million Calculation and evidence -17837000 − 249000 USD Exact free cash flow: -18086000 USD 2007-01-01 – 2007-12-31: -17837000 USD · Inspect Operating Cash Flow · Source 2007-01-01 – 2007-12-31: 249000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · IDM PHARMA, INC. · 2007-12-31 IDM PHARMA, INC. (edgar:822206) Free cash flow: -18086000 USD Concept: free-cash-flow Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/822206?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -17837000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/822206/0000936392-09-000146.txt#19828 Input fundies:CapitalExpenditure: 249000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/822206/0000936392-09-000146.txt#19957 The citation records this snapshot. The page link may show a newer release later.
2008 2008-01-01 – 2008-12-31	−USD 18.61 million Exact value Exact value: -18606000 USD 2008-01-01 – 2008-12-31: -18606000 USD Inspect Net Income Open source Share or cite Citation for Net Income · IDM PHARMA, INC. · 2008-12-31 IDM PHARMA, INC. (edgar:822206) Net Income: -18606000 USD Concept: fundies:NetIncome Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/822206/explain?concept=fundies%3ANetIncome&period=2008-12-31&surface=latest&period_type=duration&start=2008-01-01&unit=USD&dimensions= Input fundies:NetIncome: -18606000 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/822206/0000936392-09-000146.txt#18969 The citation records this snapshot. The page link may show a newer release later.	−USD 15.15 million Exact value Exact value: -15153000 USD 2008-01-01 – 2008-12-31: -15153000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · IDM PHARMA, INC. · 2008-12-31 IDM PHARMA, INC. (edgar:822206) Operating Cash Flow: -15153000 USD Concept: fundies:OperatingCashFlow Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/822206/explain?concept=fundies%3AOperatingCashFlow&period=2008-12-31&surface=latest&period_type=duration&start=2008-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -15153000 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/822206/0000936392-09-000146.txt#19828 The citation records this snapshot. The page link may show a newer release later.	USD 31,000 Exact value Exact value: 31000 USD 2008-01-01 – 2008-12-31: 31000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · IDM PHARMA, INC. · 2008-12-31 IDM PHARMA, INC. (edgar:822206) Capital Expenditure: 31000 USD Concept: fundies:CapitalExpenditure Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/822206/explain?concept=fundies%3ACapitalExpenditure&period=2008-12-31&surface=latest&period_type=duration&start=2008-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 31000 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/822206/0000936392-09-000146.txt#19957 The citation records this snapshot. The page link may show a newer release later.	−USD 15.18 million Calculation and evidence -15153000 − 31000 USD Exact free cash flow: -15184000 USD 2008-01-01 – 2008-12-31: -15153000 USD · Inspect Operating Cash Flow · Source 2008-01-01 – 2008-12-31: 31000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · IDM PHARMA, INC. · 2008-12-31 IDM PHARMA, INC. (edgar:822206) Free cash flow: -15184000 USD Concept: free-cash-flow Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/822206?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -15153000 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/822206/0000936392-09-000146.txt#19828 Input fundies:CapitalExpenditure: 31000 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/822206/0000936392-09-000146.txt#19957 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

59 filings · 0 latest values · 0 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0000822206, 822206, edgar:822206

Also known as CYTEL CORP/DE, EPIMMUNE INC

IDM PHARMA, INC.

Latest quarter

Revenue

Operating margin

Operating cash flow

Free cash flow

Trailing twelve months

Revenue

Net income

Operating cash flow

Capital expenditure

Free cash flow

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2008 2008-01-01 – 2008-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation